NanoString Technologies Inc (NSTG) Stock
NSTG is no longer traded. NanoString Technologies was delisted from the Nasdaq in February 2024.
Prices on this page are historical; the last trade was February 28, 2024 at $0.17.
NanoString Technologies stock price history
NSTG final trading statistics
- Final close
- $0.17
- Final trading day
- Feb 28, 2024
- Market cap at delisting
- $8.30M
- Shares outstanding
- 48.12M
- Final 52-week range
- $0.04 – $11.02
- Avg. volume (final 3 mo.)
- 18,035,289
- All-time high (split-adj.)
- $82.96 · Feb 2021
- All-time low (split-adj.)
- $0.04 · Feb 2024
- Return since IPO
- -97.9%
- Beta
- 1.24
- Book value / share
- -$1.05
- Price / book
- -0.16
NanoString Technologies annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $34.42M | -$44.1M | -$3.45 |
| FY2021 | $145.09M | -$115.3M | -$2.55 |
| FY2020 | $117.32M | -$110.1M | -$2.66 |
| FY2019 | $125.57M | -$40.7M | -$2.49 |
| FY2018 | $106.73M | -$77.4M | -$2.79 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About NanoString Technologies Inc
NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. On February 4, 2024, NanoString Technologies, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bank
NanoString Technologies stock FAQ
What happened to NanoString Technologies stock?
NanoString Technologies stock was delisted from the Nasdaq. Its final close was $0.17 on February 28, 2024.
Is NSTG stock still trading?
No. NSTG was delisted from the Nasdaq in February 2024 and no longer trades on a U.S. exchange.
What was the last price of NSTG stock?
NSTG closed at $0.17 on its final trading day, February 28, 2024, for a market value of about $8.30M.
What were NanoString Technologies's revenue and earnings in its last full fiscal year?
NanoString Technologies reported revenue of $34.42M and net income of -$44.1M in fiscal 2022, its last full year as a public company.
When did NanoString Technologies go public?
NanoString Technologies Inc stock began trading on June 26, 2013.